AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Fenbufen is effective in reducing mild to moderate pain, including headache, toothache, muscle pain, menstrual cramps, and pain caused by minor injuries. It works by inhibiting the production of prostaglandins, which are substances in the body that contribute to pain and inflammation.
Anti-inflammatory Effects: Fenbufen helps reduce inflammation by inhibiting the activity of cyclooxygenase enzymes (COX-1 and COX-2), which are involved in the synthesis of prostaglandins. By decreasing the levels of prostaglandins, fenbufen helps alleviate swelling, redness, and discomfort associated with inflammatory conditions such as arthritis, bursitis, and tendonitis.
Antipyretic Action: Fenbufen can lower fever by acting on the hypothalamus, a region of the brain that regulates body temperature. By inhibiting prostaglandin synthesis, it reduces fever and promotes temperature normalization in individuals with febrile conditions.
Musculoskeletal Disorders: Fenbufen is commonly prescribed for the management of musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout. It helps relieve joint pain, stiffness, and swelling, thereby improving mobility and overall quality of life.
Dysmenorrhea: Fenbufen is often used to alleviate menstrual pain (dysmenorrhea) and discomfort associated with menstrual cramps. Its analgesic and anti-inflammatory properties help reduce pelvic pain and uterine contractions, providing relief during menstruation.
Adverse Effects: Like other NSAIDs, fenbufen may cause gastrointestinal side effects such as stomach pain, nausea, indigestion, and gastrointestinal bleeding or ulcers, particularly with long-term use or at high doses. It may also increase the risk of cardiovascular events such as heart attack or stroke, especially in individuals with pre-existing cardiovascular conditions.
Renal Effects: Prolonged use of fenbufen or other NSAIDs may lead to kidney-related adverse effects, including fluid retention, decreased kidney function, and kidney damage. Patients with pre-existing renal impairment or dehydration are at higher risk of developing these complications.
Hepatic Effects: Fenbufen has the potential to cause liver damage, hepatotoxicity, or abnormal liver function tests, although such adverse effects are relatively rare. Patients with underlying liver disease or alcoholism may be more susceptible to liver-related complications.
Allergic Reactions: Some individuals may experience allergic reactions to fenbufen, manifesting as rash, itching, hives, swelling of the face or throat, difficulty breathing, or anaphylaxis. Allergic reactions require immediate medical attention and discontinuation of the medication.
Drug Interactions: Fenbufen may interact with other medications, including anticoagulants, antiplatelet drugs, corticosteroids, selective serotonin reuptake inhibitors (SSRIs), and certain herbal supplements. Concurrent use of fenbufen with these medications may increase the risk of bleeding or other adverse effects.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Streptococcus oralis | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 431 | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Streptococcus sp. Marseille-Q6470 | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | |
Acne | 0.2 | -0.2 | |
ADHD | 3.6 | 0.1 | 35 |
Age-Related Macular Degeneration and Glaucoma | 0.3 | 0.2 | 0.5 |
Allergic Rhinitis (Hay Fever) | 2 | 3.1 | -0.55 |
Allergies | 6.1 | 3.8 | 0.61 |
Allergy to milk products | 2.1 | 1.2 | 0.75 |
Alopecia (Hair Loss) | 0.6 | 0.6 | |
Alzheimer's disease | 6 | 4.9 | 0.22 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.5 | 1.3 | 0.92 |
Ankylosing spondylitis | 3.1 | 1.1 | 1.82 |
Anorexia Nervosa | 1.6 | 2.4 | -0.5 |
Antiphospholipid syndrome (APS) | 1.7 | 1.7 | |
Asthma | 4.6 | 3.1 | 0.48 |
Atherosclerosis | 2.4 | 1.7 | 0.41 |
Atrial fibrillation | 2.6 | 1.2 | 1.17 |
Autism | 7.3 | 7.2 | 0.01 |
Autoimmune Disease | 0.9 | 0.8 | 0.13 |
Barrett esophagus cancer | 0.9 | 0.3 | 2 |
benign prostatic hyperplasia | 0.4 | 0.3 | 0.33 |
Biofilm | 2.3 | 2.3 | |
Bipolar Disorder | 1.6 | 0.8 | 1 |
Brain Trauma | 0.6 | 1 | -0.67 |
Breast Cancer | 1.1 | 1.1 | |
Cancer (General) | 1.1 | 2.8 | -1.55 |
Carcinoma | 3.3 | 1.7 | 0.94 |
Celiac Disease | 3.2 | 2.8 | 0.14 |
Cerebral Palsy | 2.1 | 1 | 1.1 |
Chronic Fatigue Syndrome | 4.8 | 4.1 | 0.17 |
Chronic Kidney Disease | 3 | 1 | 2 |
Chronic Lyme | 0.6 | 0.5 | 0.2 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.8 | 1.4 | 1 |
Chronic Urticaria (Hives) | 1.7 | 1.2 | 0.42 |
Coagulation / Micro clot triggering bacteria | 1.3 | 1 | 0.3 |
Cognitive Function | 1.5 | 1.3 | 0.15 |
Colorectal Cancer | 7.3 | 1.9 | 2.84 |
Constipation | 1.3 | 0.4 | 2.25 |
Coronary artery disease | 1.6 | 2.1 | -0.31 |
COVID-19 | 9.1 | 8.8 | 0.03 |
Crohn's Disease | 6.8 | 4.1 | 0.66 |
Cushing's Syndrome (hypercortisolism) | 0.7 | -0.7 | |
cystic fibrosis | 0.7 | 1.6 | -1.29 |
d-lactic acidosis (one form of brain fog) | 0.5 | 0.5 | |
deep vein thrombosis | 2.4 | 1.1 | 1.18 |
Denture Wearers Oral Shifts | 1.9 | 1.9 | |
Depression | 8.9 | 7.3 | 0.22 |
Dermatomyositis | 0.3 | 0.2 | 0.5 |
Eczema | 1.9 | 2.5 | -0.32 |
Endometriosis | 2.2 | 1.5 | 0.47 |
Eosinophilic Esophagitis | 0.5 | 0.7 | -0.4 |
Epilepsy | 4.2 | 2.7 | 0.56 |
erectile dysfunction | 1.6 | 0.2 | 7 |
Fibromyalgia | 2.2 | 1.1 | 1 |
Functional constipation / chronic idiopathic constipation | 4.9 | 3.1 | 0.58 |
gallstone disease (gsd) | 2.8 | 1.4 | 1 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 2.4 | 1.1 | 1.18 |
Generalized anxiety disorder | 2.6 | 2 | 0.3 |
giant cell arteritis | 0.4 | -0.4 | |
Glioblastoma | 0.3 | -0.3 | |
Gout | 2.4 | 1 | 1.4 |
Graves' disease | 1.6 | 2.1 | -0.31 |
Gulf War Syndrome | 0.9 | 2.4 | -1.67 |
Halitosis | 2.1 | 0.3 | 6 |
Hashimoto's thyroiditis | 3.4 | 1.1 | 2.09 |
Heart Failure | 3.5 | 1.5 | 1.33 |
hemorrhagic stroke | 0.8 | 0.8 | |
Hidradenitis Suppurativa | 1.1 | 0.4 | 1.75 |
High Histamine/low DAO | 1.6 | 0.5 | 2.2 |
hypercholesterolemia (High Cholesterol) | 1 | 0.6 | 0.67 |
hyperglycemia | 2.2 | 2.1 | 0.05 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.1 | 7 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 3.9 | 4.8 | -0.23 |
Hypothyroidism | 0.4 | 0.5 | -0.25 |
Hypoxia | 2.3 | 2.3 | |
IgA nephropathy (IgAN) | 1.6 | 3.3 | -1.06 |
Inflammatory Bowel Disease | 8.9 | 7.8 | 0.14 |
Insomnia | 1.8 | 2.9 | -0.61 |
Intelligence | 1.6 | 1.6 | |
Intracranial aneurysms | 1.5 | 0.1 | 14 |
Irritable Bowel Syndrome | 7.5 | 4.6 | 0.63 |
ischemic stroke | 2.8 | 0.9 | 2.11 |
Liver Cirrhosis | 6.5 | 4.3 | 0.51 |
Long COVID | 5.5 | 5.7 | -0.04 |
Low bone mineral density | 0.2 | -0.2 | |
Lung Cancer | 1 | 1.3 | -0.3 |
Lymphoma | 0.4 | 0.4 | |
Mast Cell Issues / mastitis | 1.3 | 0.5 | 1.6 |
ME/CFS with IBS | 0.9 | 1.6 | -0.78 |
ME/CFS without IBS | 0.8 | 1.1 | -0.38 |
membranous nephropathy | 0.3 | 0.3 | |
Menopause | 2.2 | 0.6 | 2.67 |
Metabolic Syndrome | 5.8 | 7.1 | -0.22 |
Mood Disorders | 10 | 5.9 | 0.69 |
multiple chemical sensitivity [MCS] | 1.5 | 0.2 | 6.5 |
Multiple Sclerosis | 6.1 | 3.7 | 0.65 |
Multiple system atrophy (MSA) | 2.1 | 0.7 | 2 |
myasthenia gravis | 0.7 | 0.6 | 0.17 |
neuropathic pain | 2.2 | -2.2 | |
Neuropathy (all types) | 1 | 1.1 | -0.1 |
neuropsychiatric disorders (PANDAS, PANS) | 0.9 | 0.9 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.4 | 4 | 0.1 |
NonCeliac Gluten Sensitivity | 1.5 | 0.6 | 1.5 |
Obesity | 7.5 | 7.2 | 0.04 |
obsessive-compulsive disorder | 5.4 | 2.1 | 1.57 |
Osteoarthritis | 2 | 1.6 | 0.25 |
Osteoporosis | 1.9 | 1.7 | 0.12 |
pancreatic cancer | 1.1 | 0.3 | 2.67 |
Parkinson's Disease | 7.1 | 4.8 | 0.48 |
Polycystic ovary syndrome | 5.7 | 3.1 | 0.84 |
Postural orthostatic tachycardia syndrome | 0.4 | 0.2 | 1 |
Premenstrual dysphoric disorder | 0.6 | 0.2 | 2 |
primary biliary cholangitis | 0.7 | 1.4 | -1 |
Primary sclerosing cholangitis | 3.5 | 1.9 | 0.84 |
Psoriasis | 3.6 | 1.5 | 1.4 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.6 | 3.2 | 0.44 |
Rosacea | 0.6 | 0.6 | 0 |
Schizophrenia | 6.4 | 2.7 | 1.37 |
scoliosis | 0.5 | 0.2 | 1.5 |
sensorineural hearing loss | 0.1 | 0.1 | |
Sjögren syndrome | 2.5 | 1.9 | 0.32 |
Sleep Apnea | 1.4 | 0.8 | 0.75 |
Slow gastric motility / Gastroparesis | 1.4 | 0.2 | 6 |
Small Intestinal Bacterial Overgrowth (SIBO) | 2.3 | 0.4 | 4.75 |
Stress / posttraumatic stress disorder | 3 | 1.7 | 0.76 |
Systemic Lupus Erythematosus | 3.5 | 1.7 | 1.06 |
Tic Disorder | 1.1 | 0.5 | 1.2 |
Tourette syndrome | 0.8 | 0.3 | 1.67 |
Type 1 Diabetes | 4.4 | 3.2 | 0.38 |
Type 2 Diabetes | 6.3 | 7.3 | -0.16 |
Ulcerative colitis | 5.6 | 6.3 | -0.13 |
Unhealthy Ageing | 4 | 1.3 | 2.08 |
Vitiligo | 1.9 | 1.3 | 0.46 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]